Joe Hogan

Invisalign, Align's flagship product, has treated over 17 million patients worldwide, revolutionizing orthodontic treatment by replacing traditional metal braces with a series of custom-manufactured clear plastic aligners designed using proprietary 3D treatment planning software. Under Hogan's leadership, Align expanded Invisalign from a product primarily used for mild adult malocclusion to a comprehensive orthodontic system treating increasingly complex cases, including teenagers and children. He also drove the growth of Align's iTero intraoral scanner business, creating a digital workflow that locks dentists and orthodontists into the Align ecosystem — scan with iTero, plan with ClinCheck, manufacture with Invisalign. His key decisions involve geographic expansion (particularly in underpenetrated Asian and emerging markets), extending Invisalign to more complex orthodontic cases to compete with traditional braces, managing the growing threat from direct-to-consumer clear aligner companies and patent expiration, pricing strategy, and investment in digital dentistry platforms. The stock is highly sensitive to volume growth metrics and average selling prices.